15667-63-7Relevant articles and documents
Preparation method and device of 1-cyano-2-propenyl acetate
-
Paragraph 0035-0057, (2020/05/14)
The invention provides a preparation method of 1-cyano-2-allyl acetate. The preparation method comprises an esterification reaction and distillation. Acrolein cyanohydrin and liquid acetic anhydride are subjected to the esterification reaction in the presence of a catalyst and inorganic acid to prepare a reaction solution containing ACA, an ACA product is obtained after distillation, and the esterification reaction further comprises the step of introducing gaseous acetic anhydride into a reaction system. The invention further provides a preparation device of 1-cyano-2-allyl acetate. Accordingto the method and the device, acetic anhydride is ingeniously divided into two parts to be fed, one part is separated out to serve as acetic anhydride steam which is fed into an esterification reaction tower from the bottom of the tower, heat required by reaction can be provided, acetic acid can be effectively blown off, the esterification reaction can be accelerated through effective removal of acetic acid, and the reaction efficiency is improved. The device is characterized in that a conductivity meter is arranged in the esterification reaction tower to monitor the reaction process on line,so that the timeliness and effectiveness of reaction process control are guaranteed.
Preparation method of 1-cyano-2-propenyl acetate
-
Paragraph 0094; 0103-0108; 0117-0122; 0131-0136; 0145-0150, (2020/07/21)
The invention relates to a preparation method of 1-cyano-2-allyl acetate. The method comprises the following steps: (1) reacting hydrocyanic acid with acrolein in the presence of a first catalyst to obtain a reaction solution containing acrolein cyanohydrin; and (2) reacting the obtained reaction solution containing acrolein cyanohydrin with an esterifying agent in the presence of a second catalyst to obtain a reaction solution containing 1-cyano-2-propenyl acetate. The first catalyst and the second catalyst are the same or different and are respectively and independently N,N-dimethylaminopyridine carboxylate. According to the preparation method provided by the invention, the efficient catalyst N,N-dimethylaminopyridine carboxylate is used as a catalyst shared by two steps of reactions, and the two steps of main reactions can be efficiently catalyzed, so that the two steps of main reactions can be carried out according to an approximate stoichiometric ratio; the yield of the product 1-cyano-2-propenyl acetate can reach 99% or above, and the purity can reach 99.5% or above; and the investment is saved, and the product competitiveness is improved.
Method for synthesizing 2-acetoxyl-3-crotononitrile
-
Paragraph 0023; 0024, (2018/05/01)
The invention discloses a method for synthesizing 2-acetoxyl-3-crotononitrile. The method comprises the following steps: taking acrolein, hydrocyanic acid and acetic anhydride as raw materials, dropping mixed solution of the acrolein and the acetic anhydride into alcoholic solution of the hydrocyanic acid, performing a reaction on the mixture, so as to obtain the 2-acetoxyl-3-crotononitrile. In the method, the hydrocyanic acid replaces sodium cyanide which is used for performing a reaction with water, so that the problem that cyanide-containing waste water caused by the use of the water in thesynthesis process is avoided, and the 2-acetoxyl-3-crotononitrile is efficiently synthesized. In the method, alcohol is taken as a reaction system, acetic acid is generated in the reaction process, and all solvents can be recycled, therefore, the method has the advantages of being environmentally friendly and lowering the cost.
PROTEASOME INHIBITING ?-LACTAM PRODRUGS USEFUL FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISORDERS
-
Page/Page column 77; 78, (2018/07/29)
The present invention relates generally to proteasome inhibiting β-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
Process for the preparation of 2-hydroxy-4-(methylthio) butanoic acid or methionine by mercaptan addition
-
, (2008/06/13)
A process for the free-radical addition of a mercaptan to a nonconjugated olefinic substrate having a terminal carbon-carbon double bond is disclosed. 2-Hydroxy-4-(ethylthio)butanoic acid (HMBA) or methionine can be prepared using this method. The nonconjugated olefinic substrate has the general formula: STR1 wherein R is selected from the group consisting of --COOH, --COOR2, --CONR3 R4, --CN and --CCl3, R1 is selected from the group consisting of --OH, --OCOR2, --NHCOR2 and --NH2, R2 is selected from the group consisting of alkyl, cycloalkyl and aryl and R3 and R4 are independently selected from the group consisting of --H and R2.
Synthesis of 2-Hydroxy-3-methyl-2-hexen-4-olid
Stach, Hans,Huggenberg, Walter,Hesse, Manfred
, p. 369 - 374 (2007/10/02)
The title compound 13a, a substance used in food-flavoring, was synthesized in 89percent overall yield, starting from methyl 2-hydroxy-3-butenoate (3a).The key step in this transformation is the isomerization of the C=C bond in 3a which yielded methyl 2-oxobutanoate as an intermediate.The latter underwent a self-condensation yielding 2-hydroxy-4-(methoxycarbonyl)-3-methyl-2-hexen-4-olid (11a), which, after hyrolysis and decarboxylation, gave 13a.In addition the syntheses of five other compounds related to 13a are reported.